Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Tarnowskie Gory

12 clinical trials in Tarnowskie Gory, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Tarnowskie Gory at a glance
12
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

12 trials in Tarnowskie Gory

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Amgen Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyebiotech Limited
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Novartis Pharma AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Alvotech Swiss AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cemdisiran
  • Sponsor:Regeneron Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Eye103
  • Sponsor:Eyebiotech Limited
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ANX007
  • Sponsor:Annexon Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ranibizumab
  • Sponsor:Opthea Limited
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Rophibio Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Eye103
  • Sponsor:Eyebiotech Limited

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Tarnowskie Gory

What the registry says about research in the country

01 Age-Related Macular Degeneration Research

Groundbreaking studies focusing on geographic atrophy and neovascular AMD, exploring innovative treatment approaches through intravitreal injections and combination therapies.

  • Geographic Atrophy Treatment Studies
  • Complement Inhibition Research
  • Visual Function Assessment

Multiple therapeutic interventions being evaluated to slow disease progression and preserve vision.

02 Thyroid Eye Disease Studies

Clinical investigations examining the effectiveness of satralizumab for patients with moderate-to-severe thyroid eye disease, focusing on proptosis response.

  • Subcutaneous Treatment Evaluation
  • Proptosis Management
  • Safety Assessment Protocols

Research aimed at developing new treatment options for this challenging ocular condition.

03 Diabetic Eye Complications

Innovative research comparing EYE103 with established anti-VEGF treatments for diabetic macular edema, measuring improvements in visual acuity.

  • Visual Acuity Measurement
  • Long-term Efficacy Studies
  • Treatment Comparison Analysis

Comprehensive evaluation of new therapeutic options for diabetic eye complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.